May 2, 2025 03:08 PM EDTUpdated 03:53 PM
FDA+

Ex­clu­sive: Af­ter FDA fir­ings, drug re­view­ers are asked to vol­un­teer for ad­min­is­tra­tive work

Zachary Brennan

Senior Editor

Lead­er­ship in the FDA’s Of­fice of New Drugs sent an email to staff Fri­day af­ter­noon ask­ing if any­one would vol­un­teer to take on more ad­min­is­tra­tive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

As­traZeneca, No­var­tis ex­e­cute ‘US for US’ strat­e­gy as phar­ma tar­iffs near

Drug­mak­ers ex­ploit can­cer’s ‘lethal­i­ties’ to make next class of tar­get­ed ther­a­pies, with first re­sults for ...

Ex­clu­sive: Ver­tex drops AAV gene ther­a­py re­search, tR­NA ther­a­py part­ner­ship

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

Lil­ly meets sales ex­pec­ta­tions, but No­vo gains on PBM win

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times